Steriod metabolism by human normal thyroid, nodular goitre and thyroid cancer. by Miller, W. R. et al.
Br. J. Cancer ( 1974) 30, 284
Short Communication
STEROID METABOLISM BY HUMAN NORMAL THYROID, NODULAR
GOITRE AND THYROID CANCER
W. R. MILLER, A. A. SHIN-AS AND A. P. M. FORREST
Fromn the Departments of Clinical Surgery and Pathology, Royal Infirmary, Edinburgh EH3 9YWl
Received 4 February 1974.
PREVIOUS studies (Adams and Wong,
1968; Jones et al., 1970; Miller et al.,
1973) have shown that both normal and
neoplastic breast tissues perform steroid
conversions similar to those in the classic
steroid secreting organs of the ovary,
testis and adrenal. The present paper
describes a study of human thyroid
tissue used to determine the potential of
normal and neoplastic endocrine tissue
ofanother type to metabolize C19 steroids
in vitro.
In particular, attention was focused
upon the transformation of DHA to
testosterone and the 5a reduction of
testosterone, activities which produce
metabolites of greater biological activity
than the parent substrate.
MATERIALS AND METHODS
Three specimens of thyroid cancer of
adenocarcinomatous (or follicular) type (Fig.
1) and 3 of simple nodular goitre (Fig. 2)
were examined. Normal thyroid tissue also
was obtained from 3 patients; one of these
had no thyroid disease, one had a gland
containing a carcinoma, the other a nodular
goitre. In the latter two instances the tissue
was histologically normal. All material was
freshly obtained from the operating theatre
and taken in the frozen section laboratory for
immediate incubation.
All tissues were processed at 0°C until
incubation was carried out (within 30 min
of tissue removal). The specimens were
finely sliced and incubated for 2 h at 37°C in
Krebs-Ringer phosphate buffer, pH 7-4
(10 ml/g tissue) containing an NADPH
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generating system (200 1umol glucose-6-phos-
phate, 25 mg NADP and 50 units glucose-6-
phosphate dehydrogenase) and the radio-
active precursors: 20 MCi(70Z-3H)dehydro-
epiandrosterone (DHA) and 2 tCi(4-14C)
testosterone.
The steroid interconversions were then
determined by measuring the percentage
incorporation of the appropriate radioactive
labels into the various purified metabolites.
The methods for steroid purification and
characterization have already been described
in detail (Miller, Hamilton and Forrest,
1974).
RESULTS
The results of these experiments are
presented in the accompanying Table.
Normal, goitrous and malignant thyroid
tissue were all capable of extensively
metabolizing the DHA precursor. Testo-
sterone was isolated as a metabolite of
DHA in each type of thyroid tissue, but
it accounted for only a small amount of
the precursor used.
By contrast, the metabolism of testo-
sterone by the same tissues was slight and
in 2 of the 3 normal thyroid tissues,
metabolism was entirely absent. In com-
parison with normal thyroid, the metabo-
lism oftestosterone was greater in nodular
and malignant tissue. Both 5ac dihydro-
testosterone and 5ox androstanediol were
characterizedasmetabolites oftestosterone
in nodular and malignant tissue, but there
was no evidence for 5x reduced productsSTEROID METABOLISM BY HUMAN NORMAL THYROID 285
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TABLE.-Metabolism of (7a-3H)dehydroepiandrosterone and (4-14C)testosterone by
Human Thyroid Tissue
Testosterone
Patient
1
2
3
4
5
6
7
Age
and
sex
8M
27M
67F
58F
25F
54F
18F
DHA
A- A
Histology of % as
tissue % metabolized testosterone
38 40
52 - 50
92-91
95-17
79*10
51- 13
59-37
65-67
65 70
0-17
0
3-16
0
0-63
0 53
1 38
0-26
0-21
Adenocarcinoma
Normal tissue
Adenocarcinoma
Adenocarcinoma
Nodular goitre
Normal tissue
Nodular goitre
Nodular goitre
Normal tissue
in normal tissue even when it was associ-
ated with neoplastic tissue possessing 5ax
reductase activity.
Evidence for the conversion of either
DHA or testosterone to 16x hydroxylated
derivatives or oestrogen was not detected
in any incubation material.
DISCUSSION
These results confirm the observations
of Schneider et al. (1972) that thyroid
tissue can metabolize DHA extensively.
This ability is not confined to normal
tissue, but is also present in both goitrous
and malignant states.
High metabolism was restricted to
DHA andthe samethyroidtissues metabo-
lized much less of the testosterone pre-
cursor. Small but significant amounts of
both 5ax dihydrotestosterone and 5oc andro-
stanediol were formed from testosterone
in incubations of both goitrous and
malignant thyroid. No such evidence for
the 5x reduction oftestosterone was found
in the 3 incubations of normal thyroid,
despite the fact that thyroxine stimulates
5x reduction in other tissues (Tomkins,
Gordon and McGuire, 1960).
Intwoinstances, 5ac reduction inpatho-
logical thyroid tissues was obtained even
when the adjacent normal thyroid did
not display the activity. Although the
number of incubations is too small to
draw firm conclusions, the possibility
exists that pathological change in the
% as
dihydro- % as
% metabolized testosterone androstanediol
18-80
0
10*10
10-10
4-99
0
16-80
2*61
2 80
0-24
0
0-14
0 39
0-61
0
0-48
0
0-18
0
0-49
0-15
0
0-13
0
thyroid is accompanied by the acquisition
ofpotential to perform steroid conversions
not shown in normal tissue.
In a previous report (Miller et al.,
1973) we have described the metabolism
of DHA and testosterone by human
normal and neoplastic breast tissues,
using identical methods to those used for
the thyroid tissue studied in this com-
munication. It is worth noting that the
amounts of the individual steroid precur-
sors metabolized were different in the two
types of tissue, thyroid showing greater
metabolism of DHA but less of testo-
sterone, compared with breast tissue.
Nevertheless, with the exception of
normal thyroidtissue, the production of5o
dihydrotestosterone and 50c androstane-
diol from testosterone was quantitatively
similar in thyroid and breast tissues, as
was the conversion ofDHA to testosterone
in all tissues examined. This suggests
that these conversions are relatively non-
specific. Further evidence for this is the
demonstration of similar transformations
in human skin (Hodgins, 1971; Wilson,
1972) and metastatic deposits of a bron-
chiogenic cancer (Miller, unpublished
results).
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